Application
Antibodies tested include p-c-Src (Tyr 530): (A,B,C) and c-Src (17AT28): (D,E,F).
Application
Antibodies tested include p-c-Src (Tyr 530): (A, B, C) and c-Src (17AT28): (D, E, F).
Application
Western blot analysis of c-Src phosphorylation in untreated (A) and lambda protein phosphatase treated (B) Jurkat whole cell lysates.
Application
Western blot analysis of c-Src phosphorylation in pervanadate treated (A) and pervanadate and lambda protein phosphatase treated (B) Jurkat whole cell lysates.
Application
Western blot analysis of c-Src phosphorylation in non-transfected: (A) and human c-Src transfected: (B) 293T whole cell lysates.
Application
Western blot analysis of c-Src phosphorylation in untreated (A), EGF treated (B) and EGF and lambda protein phosphatase treated (C) HEK293 whole cell lysates.
Application
Western blot analysis of phosphorylated c-Src expression in untreated (A) and EGF + serum-treated (B) 293 whole cell lysates.
Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing cytoplasmic staining.